Diagnostic utility of exome sequencing for inherited peripheral neuropathies

Introduction. Hereditary motor and sensory neuropathies, a highly genetic heterogeneous group of disorders, have a phenotype caused by peripheral nerve damage.

Purpose of the study – to assess the extent of genetic heterogeneity of hereditary motor and sensory neuropathies in Russian patients and to evaluate the diagnostic effectiveness of using full-exome research methods to find the genetic cause of hereditary motor and sensory neuropathies.

Materials and methods. The material for the study was DNA samples from 51 patients and their family members referred for whole exome sequencing to the DNA-diagnostics laboratory of Research Centre for Medical Genetics in 2017–2019. Methods: whole exome sequencing, Sanger sequencing, restriction fragment length polymorphism.

Results. Whole exome sequencing in combination with segregation analysis of the pathogenic variants in families allowed to determine the cause of the disease in 41 % of cases. In another 16 % of cases, candidate genetic variants as a possible cause of the disease were revealed, but additional studies are needed to confirm it. The most frequently mutated gene was MFN2 caused neuropathy in 6 unrelated families. MPZ gene mutations were detected in two families, AARS gene mutations were revealed in another two families, and mutations in GJB1, HINT1, INF2, LRSAM1, LITAF, MME, NEFL, WWOX were detected once. Among the causal variants, mutations in B4GALNT1 caused spastic paraplegia, in COL6A1 led to Bethlem’s congenital muscular dystrophy, and in SYT2 caused congenital myasthenic syndrome indicating difficulties in differential diagnosis of inherited neuromuscular disorders. A PMP22 duplication was detected in 2 families prior to whole exome sequencing.

Conclusion. Whole exome sequencing is very important for finding the molecular cause of hereditary motor and sensory neuropathies. In most cases, additional methods should be used to clarify the pathogenicity of variants detected by whole exome sequencing. However, it is necessary to remember that the most common cause of the disease is a large duplication of the region 17p11.2.

1. Barreto L.C.L.S., Oliveira F.S., Nunes P.S. et al. Epidemiologic study of Charcot–Marie–Tooth disease: a systematic review. Neuroepidemiology 2016;46(3):157–65. DOI: 10.1159/000443706. PMID: 26849231.

2. Baets J., Timmerman V. Inherited peripheral neuropathies: a myriad of genes and complex phenotypes. Brain 2011;134(6):1587–90. DOI: 10.1093/brain/awr114.

3. Drew A.P., Zhu D., Kidambi A. et al. Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing. Mol Genet Genomic Med 2015;3(2):143–54. DOI: 10.1002/mgg3.126. PMID: 25802885.

4. Hartley T., Wagner J.D., WarmanChardon J. et al. Whole-exome sequencing is a valuable diagnostic tool for inherited peripheral neuropathies: Outcomes from a cohort of 50 families. Clin Genet 2018;93(2):301–9. DOI: 10.1111/cge.13101. PMID: 28708278.

5. Schabhüttl M., Wieland T., Senderek J. et al. Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges. J Neurol 2014;(261):970–82. DOI: 10.1007/s00415-014-7289-8. PMID: 24627108.

6. Gonzaga-Jauregui C., Harel T., Gambin T. et al. Exome sequence analysis suggests that genetic burden contributes to phenotypic variability and complex neuropathy. Cell Rep 2015;12(7):1169–83. DOI: 10.1016/j.celrep.2015.07.023. PMID: 26257172.

7. Richards S., Aziz N., Bale S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;(17):405–23. DOI: 10.1038/gim.2015.30. PMID: 25741868.

8. Shchagina O.A., Dadali E.L., Fedotov V.P., Polyakov A.V. The spectrum of mutations in the MFN2 gene in patients with hereditary motor-sensory neuropathy type II A. Medicinskaya genetika = Medical genetics 2006;5(9):21–6. (In Russ.).

9. Dadali E.L., Shchagina O.A., Fedotov V.P. Clinical and genetic features of type IIA motor-sensory neuropathy. Annaly klinicheskoj i eksperimental’noj nevrologii = Annals of Clinical and Experimental Neurology 2007;1(4):10–5. (In Russ.).

10. Milovidova T.B., Dadali E.L., Fedotov V.P. et al. Clinical-genetic correlations in the hereditary motor-sensor neuropathy caused by mutations in the MPZ (P0) gene. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov journal of neurology and psychiatry 2011;111(12):48–55. (In Russ.).

11. Latour P., Thauvin-Robinet C., BaudeletMéry C. et al. A major determinant for binding and aminoacylation of tRNAAla in cytoplasmic alanyl-trna synthetase is mutated in dominant axonal charcotmarie-tooth disease. Am J Hum Genet 2010;86(1):77–82. DOI: 10.1016/j.ajhg.2009.12.005. PMID: 20045102.

12. Shchagina O.A., Milovidova T.B., Murtazina A.F. et al. HINT1 gene pathogenic variants: the most common cause of recessive hereditary motor and sensory neuropathies in Russian patients. Mol Biol Rep 2020;(47):1331–7. DOI: 10.1007/s11033-019-05238-z.

13. Dadali E.L., Nikitin S.S., Kurbatov S.A. et al. Clinical and genetic characteristics of autosomal recessive axonal neuropathy with neuromyotonia in Russian patients. Nervno-myshechnye bolezni = Neuromuscular diseases 2017;7(3):47–55. (In Russ.). DOI: 10.17650/2222-8721-2017-7-3-47-55.